Breast enhancement using Macrolane™: a report of complications in three patients and a review of this new product.
Macrolane™, an injectable compound composed of hyaluronic acid, has recently been marketed for breast enhancement. Three patients who presented to the authors with complications soon after treatment elsewhere are reported. One had severe infection and two had grade 3 capsular contracture. All three patients underwent a surgical procedure to treat their complication. The use of Macrolane™ for breast enhancement is reviewed together with previously published data.
McCleave
M J
MJ
The Department of Plastic & Reconstructive Surgery, The Royal Adelaide Hospital, North Terrace Adelaide, 5000, Australia. mmccleave@hotmail.com
Grover
R
R
Jones
B M
BM
D000328:Adult; D019928:Breast Implantation / Q000379:methods*; D018427:Breast Implants / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D014946:Wound Infection / Q000209:etiology
D006820:Hyaluronic Acid